PRECISION BIOSCIENCES INC
Clinical-stage gene editing company developing therapies for rare genetic diseases.
DTIL | US
Overview
Corporate Details
- ISIN(s):
- US74019P2074
- LEI:
- Country:
- United States of America
- Address:
- 302 EAST PETTIGREW STREET, 27701 DURHAM
Description
Precision BioSciences is a clinical-stage gene editing company focused on developing therapeutic candidates using its proprietary ARCUS® genome editing platform. ARCUS is a novel technology that utilizes sequence-specific DNA-cutting enzymes, or nucleases, to perform targeted edits within living cells and tissues. The platform is designed to insert (knock-in), remove (knock-out), or repair DNA sequences. The company's primary application of this technology is the development of in vivo gene editing therapies aimed at overcoming and potentially curing rare genetic diseases and other hard-to-treat conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PRECISION BIOSCIENCES INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PRECISION BIOSCIENCES INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PRECISION BIOSCIENCES INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
